A Marlboro cigarette.
Daniel Acker | Bloomberg | Getty Images
Marlboro moms and dad Altria is asking the Food and Drug Administration to assist it get the word out that nicotine does not trigger cancer.
CNBC on Thursday got a copy of a letter Altria sent out to the FDA asking the company to assist get the message out about nicotine as part of a proposed ad campaign on the threats of tobacco usage.
“We have received the letter and will respond directly to the company,” FDA spokesperson Alison Hunt informed CNBC in an e-mail.
Altria was not instantly readily available to talk about the matter.
In the letter, which was dated Feb. 25 and signed by Paige C. Magness, senior vice president of regulative affairs, Altria mentioned federal government research studies on the misperceptions about nicotine. It stated that cleaning up such misperceptions would assist standard cigarette smokers shift to noncombustible approaches of utilizing nicotine that are possibly less dangerous than items with smoke.
Bloomberg News initially reported on the letter Thursday.
While the huge bulk of Altria’s earnings originates from offering cigarettes and stogies, it likewise owns a stake in vaping business Juul and nicotine pouch brand name On!, and it markets IQOS, a smoke-free tobacco item that heats up tobacco rather of burning it, in the U.S.
There are at least 60 carcinogens in cigarette smoke, however these more recent items provide nicotine without the smoke.
As Altria’s regulator, the FDA can identify what declares it can make about its items. The FDA has actually permitted Altria to market IQOS as offering users with less direct exposure to hazardous chemicals than cigarette smoke.
Nicotine is the component that makes tobacco addicting, and it might have other unfavorable health impacts. In its report, Bloomberg stated research studies have actually revealed that nicotine can hinder brain advancement and birth results and serves as a farming toxin in big dosages.
